ImmunoGen, Inc.
Cytotoxic benzodiazepine derivatives
Last updated:
Abstract:
The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VI). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Status:
Grant
Type:
Utility
Filling date:
15 Jun 2020
Issue date:
14 Sep 2021